TOURMALINE BIO INC (TRML) Stock Analyst Ratings
USA - NASDAQ:TRML - US89157D1054 - Common Stock
47.98 USD
0 (0%)
47.98 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 71% to TRML. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 48.96. This target is 2.04% above the current price.
TRML was analyzed by 15 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about TRML.
In the last month the buy percentage fell by 15 points. So the trust of analysts is decreasing.
TRML was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-15 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2025-09-11 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-09-10 | Chardan Capital | Downgrade | Buy -> Neutral |
| 2025-09-10 | Guggenheim | Downgrade | Buy -> Neutral |
| 2025-09-10 | Truist Securities | Downgrade | Buy -> Hold |
| 2025-09-10 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-09-09 | LifeSci Capital | Downgrade | Outperform -> Market Perform |
| 2025-09-09 | Wedbush | Downgrade | Outperform -> Neutral |
| 2025-09-09 | Jefferies | Downgrade | Buy -> Hold |
| 2025-08-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-14 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-05-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-23 | Chardan Capital | Initiate | Buy |
| 2025-03-14 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-03-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-06 | Wedbush | Initiate | Outperform |
| 2025-02-24 | LifeSci Capital | Initiate | Outperform |
| 2024-12-11 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-12-11 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-12-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-06 | BMO Capital | Initiate | Outperform |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-25 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-03-20 | Jefferies | Maintains | Buy -> Buy |
| 2024-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-15 | Jefferies | Initiate | Buy |
| 2023-11-17 | Truist Securities | Initiate | Buy |
TOURMALINE BIO INC / TRML FAQ
Can you provide the average price target for TOURMALINE BIO INC stock?
15 analysts have analysed TRML and the average price target is 48.96 USD. This implies a price increase of 2.04% is expected in the next year compared to the current price of 47.98.
What is the consensus rating for TOURMALINE BIO INC (TRML) stock?
The consensus rating for TOURMALINE BIO INC (TRML) is 70.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for TRML stock?
The number of analysts covering TOURMALINE BIO INC (TRML) is 15.